EPI vs IBB
WisdomTree India Earnings Fund vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.84% for EPI.
- • IBB pays a higher dividend yield (0.22%).
Side-by-side metrics
| Metric | EPI | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.84% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $2.12B | $9.09B |
YTD return | -9.01% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.59 | 0.69 |
P/E ratio | 16.75 | 24.79 |
Last price | $42.40 | $196.62 |
Inception | — | — |
Issuer | WisdomTree | iShares |
EPI top holdings
| RELIANCE.NS | Reliance Industries Ltd | 6.59% |
| ICICIBANK.NS | ICICI Bank Ltd | 5.38% |
| HDFCBANK.NS | HDFC Bank Ltd | 5.01% |
| SBIN.NS | State Bank of India | 2.99% |
| COALINDIA.NS | Coal India Ltd | 2.71% |
| 500312 | Oil & Natural Gas Corp Ltd | 2.57% |
| INFY.NS | Infosys Ltd | 2.50% |
| HINDALCO.NS | Hindalco Industries Ltd | 2.36% |
| NTPC.BO | NTPC Ltd | 2.17% |
| POWERGRID.BO | Power Grid Corp Of India Ltd | 2.01% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EPI
EPI (WisdomTree India Earnings Fund) is Indian companies weighted by earnings. Managed by WisdomTree, the fund carries $2.1B in assets under management, an expense ratio of 0.84%. Its largest holding is Reliance Industries Ltd (RELIANCE.NS), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.